Your browser doesn't support javascript.
loading
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
Li, Jingmei; Wen, Wei Xiong; Eklund, Martin; Kvist, Anders; Eriksson, Mikael; Christensen, Helene Nordahl; Torstensson, Astrid; Bajalica-Lagercrantz, Svetlana; Dunning, Alison M; Decker, Brennan; Allen, Jamie; Luccarini, Craig; Pooley, Karen; Simard, Jacques; Dorling, Leila; Easton, Douglas F; Teo, Soo-Hwang; Hall, Per; Borg, Åke; Grönberg, Henrik; Czene, Kamila.
Afiliación
  • Li J; Human Genetics, Genome Institute of Singapore, Singapore, Singapore.
  • Wen WX; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Eklund M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Kvist A; Cancer Research Malaysia, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.
  • Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Christensen HN; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Torstensson A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Bajalica-Lagercrantz S; AstraZeneca Nordic-Baltic, Södertälje, Sweden.
  • Dunning AM; AstraZeneca Nordic-Baltic, Södertälje, Sweden.
  • Decker B; Department of Oncology-Pathology, Karolinska Universitetssjukhuset, Stockholm, Sweden.
  • Allen J; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.
  • Luccarini C; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.
  • Pooley K; Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
  • Simard J; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Dorling L; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.
  • Easton DF; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.
  • Teo SH; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.
  • Hall P; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Canada Research Chair in Oncogenetics, Université Laval, Quebec City, Canada.
  • Borg Å; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.
  • Grönberg H; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.
  • Czene K; Cancer Research Malaysia, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.
Int J Cancer ; 144(5): 1195-1204, 2019 03 01.
Article en En | MEDLINE | ID: mdl-30175445
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 / Mutación Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 / Mutación Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Singapur